17d • General discussion
Reta Phase III update
Trial: Type 2 Diabetes + Obesity (40 weeks)
✅ Efficacy
- Weight loss: Up to 16.8% body weight loss (high dose 12mg/wk) ~15.3% average overall
- A1C reduction: 1.7% – 2.0% decrease
- No plateau observed Weight was still dropping at end of study (which means more weight loss expected)
1
0 comments
Reta Phase III update
powered by
Suggested communities
Powered by